borderline significantP = 0.054
In addition, GFAP staining indicated a borderline significant ( P = 0.054) 35% reduction in astrogliosis in ECS-treated EAE mice as compared with control EAE mice ( Figure 2, I–K ).
In addition, GFAP staining indicated a borderline significant ( P = 0.054) 35% reduction in astrogliosis in ECS-treated EAE mice as compared with control EAE mice ( Figure 2, I–K ).